赛默飞世尔将微生物业务出售至阿斯特欧私募基金

环球市场播报04-27

赛默飞世尔达成协议，以约10.75 亿美元价格，将旗下微生物业务出售给欧洲私募机构阿斯特欧（Astorg）赛默飞世尔表示，该微生物业务去年实现营收 6.45 亿美元。　　内容摘要　　赛默飞世尔科技已签署协议，将旗下微生物业务作价约 10.75 亿美元，出售给欧洲私募股权公司阿斯特欧。　　赛默飞世尔于周一宣布，此次待售的微生物业务，主要为临床检测、制药研发及食品安全领域，提供抗生素药敏检测与...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2630313623?lang=zh_CN&edition=full","thumbnail":"http://n.sinaimg.cn/finance/transform/116/w550h366/20260427/b0d4-601dc20b83ee6c895f282848d10608e5.png","is_english":false,"pubTime":"2026-04-27 23:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2630313623","market":"us","top_or_hot":-1,"title":"赛默飞世尔将微生物业务出售至阿斯特欧私募基金","media":"环球市场播报","content":"<div>\n<p>赛默飞世尔达成协议，以约10.75 亿美元价格，将旗下微生物业务出售给欧洲私募机构阿斯特欧（Astorg）\n赛默飞世尔表示，该微生物业务去年实现营收 6.45 亿美元。\n　　内容摘要\n　　赛默飞世尔科技已签署协议，将旗下微生物业务作价约 10.75 亿美元，出售给欧洲私募股权公司阿斯特欧。\n　　赛默飞世尔于周一宣布，此次待售的微生物业务，主要为临床检测、制药研发及食品安全领域，提供抗生素药敏检测与...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2026-04-27/doc-inhvyefa7797766.shtml\">网页链接</a>\n\n</div>\n","source":"sina_us","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>赛默飞世尔将微生物业务出售至阿斯特欧私募基金</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n赛默飞世尔将微生物业务出售至阿斯特欧私募基金\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-27 23:20 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2026-04-27/doc-inhvyefa7797766.shtml><strong>环球市场播报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>赛默飞世尔达成协议，以约10.75 亿美元价格，将旗下微生物业务出售给欧洲私募机构阿斯特欧（Astorg）\n赛默飞世尔表示，该微生物业务去年实现营收 6.45 亿美元。\n　　内容摘要\n　　赛默飞世尔科技已签署协议，将旗下微生物业务作价约 10.75 亿美元，出售给欧洲私募股权公司阿斯特欧。\n　　赛默飞世尔于周一宣布，此次待售的微生物业务，主要为临床检测、制药研发及食品安全领域，提供抗生素药敏检测与...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2026-04-27/doc-inhvyefa7797766.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1803068623.USD","symbol_name":"TEMPLETON GLOBAL CLIMATE CHANGE \"AH1\" (USDHDG) ACC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-27/doc-inhvyefa7797766.shtml","article_id":"2630313623","we_media_id":null,"thumbnails":["http://n.sinaimg.cn/finance/transform/116/w550h366/20260427/b0d4-601dc20b83ee6c895f282848d10608e5.png"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2630313623","pubTimestamp":1777303211,"columns":[],"sourceInfo":{"source_id":"sina_us","name":"新浪美股"},"weMediaInfo":null,"summary":"赛默飞世尔达成协议，以约10.75 亿美元价格，将旗下微生物业务出售给欧洲私募机构阿斯特欧。赛默飞世尔表示，该微生物业务去年实现营收 6.45 亿美元。　　赛默飞世尔科技已签署协议，将旗下微生物业务作价约 10.75 亿美元，出售给欧洲私募股权公司阿斯特欧。赛默飞世尔预计，业务剥离完成后的首个完整财年，公司调整后每股收益将减少 0.15 美元。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1803068623.USD":"TEMPLETON GLOBAL CLIMATE CHANGE \"AH1\" (USDHDG) ACC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU2264538146.SGD":"Fullerton Lux Funds - Global Absolute Alpha A Acc SGD","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","LU2125909759.SGD":"Natixis Thematics Safety H-R/A SGD","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","LU1815333072.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"AUP\" (USD) INC","LU1623119135.USD":"Natixis Mirova Global Sustainable Equity R-NPF/A USD","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00B19Z8X17.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH  \"AG\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU1923622291.USD":"Natixis Thematics Safety R/A USD","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","LU2720916845.USD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (USD) ACC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC","BK4585":"ETF&股票定投概念","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU2360108059.USD":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU0557290698.USD":"施罗德环球可持续增长基金","BK4535":"淡马锡持仓","TMO":"赛默飞世尔","LU2298321311.HKD":"BGF CIRCULAR ECONOMY \"A\" (HKDHDG) ACC","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU1720051108.HKD":"ALLIANZ GLOBAL ARTIFICIAL INTELLIGENCE \"AT\" (HKD) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","LU0096362180.USD":"CT (LUX) I GLOBAL FOCUS \"DU\" (USD)","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1670627923.USD":"M&G (LUX) NORTH AMERICAN DIVIDEND \"A\" (USD) ACC","LU0342679015.USD":"ALLIANZ GLOBAL EQUITY UNCONSTRAINED \"AT\" (USD) ACC"},"translate_title":"Thermo Fisher sells microbiology business to Asteo private equity fund","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TMO":1.5},"content_text":"赛默飞世尔达成协议，以约10.75 亿美元价格，将旗下微生物业务出售给欧洲私募机构阿斯特欧（Astorg）\n赛默飞世尔表示，该微生物业务去年实现营收 6.45 亿美元。\n　　内容摘要\n　　赛默飞世尔科技已签署协议，将旗下微生物业务作价约 10.75 亿美元，出售给欧洲私募股权公司阿斯特欧。\n　　赛默飞世尔于周一宣布，此次待售的微生物业务，主要为临床检测、制药研发及食品安全领域，提供抗生素药敏检测与微生物培养基整体解决方案；该业务去年营收达 6.45 亿美元。\n　　这家总部位于马萨诸塞州沃尔瑟姆市的生命科学巨头，2025 年整体营收接近446 亿美元。\n　　本次交易对价包含现金及 500 万美元卖方票据，预计于今年下半年完成交割。赛默飞世尔预计，业务剥离完成后的首个完整财年，公司调整后每股收益将减少 0.15 美元。该微生物部门拥有约 2400 名员工，在全球运营 13 处生产及研发基地。\n　　阿斯特欧专注布局医疗健康、科技与商业服务领域投资，目前资产管理规模超280 亿美元。机构于 2024 年完成旗舰并购基金Astorg VIII募集，募资规模 44 亿欧元（约合 52 亿美元）。\n　　今年 3 月，阿斯特欧曾联合财团，将终端数据解决方案企业克莱里奥控股（Clario Holdings）以近 89 亿美元出售给赛默飞世尔并完成交割。\n　　本次收购，是阿斯特欧在医疗健康赛道最新的企业分拆并购案例。2024 年末，该机构收购库克医疗（Cook Medical）生殖健康业务，并将其与加拿大辅助生殖技术上市公司汉密尔顿索恩（Hamilton Thorne）合并；后者同年被阿斯特欧私有化收购。合并后的新公司已于去年正式更名为Nexpring Health。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2630313623","isCrawlerRequest":true}